MicroRNA-98-5p ameliorates oxygen-glucose deprivation/reoxygenation (OGD/R)-induced neuronal injury by inhibiting Bach1 and promoting Nrf2/ARE signaling
- PMID: 30449595
- DOI: 10.1016/j.bbrc.2018.10.182
MicroRNA-98-5p ameliorates oxygen-glucose deprivation/reoxygenation (OGD/R)-induced neuronal injury by inhibiting Bach1 and promoting Nrf2/ARE signaling
Abstract
MicroRNA-98-5p (miR-98-5p) is a stress-related microRNA (miRNA) that plays an important role in regulating cell survival, apoptosis, and oxidative stress in multiple cell types and diseases. However, little is known about the role of miR-98-5p in cerebral ischemia/reperfusion injury. In this study, we investigated the role and mechanism of miR-98-5p in regulating neuronal injury induced by oxygen-glucose deprivation/reoxygenation (OGD/R), an in vitro model of cerebral ischemia/reperfusion injury. We found that miR-98 expression was significantly altered in neurons in response to OGD/R treatment. Functional experiments showed that overexpression of miR-98-5p inhibited OGD/R-induced apoptosis and reactive oxygen species (ROS) production in neurons, whereas inhibition of miR-98-5p showed the opposite effect. Interestingly, bioinformatics analysis predicted that BTB and CNC homology 1 (Bach1) was a potential target gene of miR-98-5p, that was verified by dual-luciferase reporter assay. Moreover, overexpression of miR-98-5p inhibited Bach1 expression while suppression of miR-98-5p promoted Bach1 expression in neurons. Notably, miR-98-5p was shown to regulate the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) and the activity of the antioxidant response element (ARE). However, overexpression of Bach1 or silencing of Nrf2 significantly abolished the miR-98-5p-mediated neuroprotective effect. Overall, these results demonstrate that miR-98-5p ameliorates OGD/R-induced neuronal injury in vitro through targeting to promote activation of Nrf2/ARE signaling. Our study suggests that miR-98-5p may play a potential role in cerebral ischemia/reperfusion injury and represents a potential therapeutic target for neuroprotection.
Keywords: Bach1; Nrf2; Oxygen-glucose deprivation/reoxygenation; miR-98-5p.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Inhibition of microRNA-199a-5p ameliorates oxygen-glucose deprivation/reoxygenation-induced apoptosis and oxidative stress in HT22 neurons by targeting Brg1 to activate Nrf2/HO-1 signalling.Clin Exp Pharmacol Physiol. 2020 Jun;47(6):1020-1029. doi: 10.1111/1440-1681.13265. Epub 2020 Feb 10. Clin Exp Pharmacol Physiol. 2020. PMID: 31990992
-
Downregulation of microRNA-302b-3p relieves oxygen-glucose deprivation/re-oxygenation induced injury in murine hippocampal neurons through up-regulating Nrf2 signaling by targeting fibroblast growth factor 15/19.Chem Biol Interact. 2019 Aug 25;309:108705. doi: 10.1016/j.cbi.2019.06.018. Epub 2019 Jun 11. Chem Biol Interact. 2019. PMID: 31199929
-
Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway.Biomed Pharmacother. 2017 May;89:1187-1195. doi: 10.1016/j.biopha.2017.03.011. Epub 2017 Mar 14. Biomed Pharmacother. 2017. PMID: 28320085
-
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome.Free Radic Biol Med. 2022 Apr;183:1-13. doi: 10.1016/j.freeradbiomed.2022.03.006. Epub 2022 Mar 11. Free Radic Biol Med. 2022. PMID: 35283228 Review.
-
Inhibiting BTB domain and CNC homolog 1 (Bach1) as an alternative to increase Nrf2 activation in chronic diseases.Biochim Biophys Acta Gen Subj. 2022 Jun;1866(6):130129. doi: 10.1016/j.bbagen.2022.130129. Epub 2022 Mar 12. Biochim Biophys Acta Gen Subj. 2022. PMID: 35292311 Review.
Cited by
-
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.Oxid Med Cell Longev. 2019 Jul 14;2019:9372182. doi: 10.1155/2019/9372182. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31396308 Free PMC article. Review.
-
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia.Antioxidants (Basel). 2020 Aug 21;9(9):779. doi: 10.3390/antiox9090779. Antioxidants (Basel). 2020. PMID: 32839417 Free PMC article. Review.
-
A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema.J Clin Med. 2020 Sep 10;9(9):2920. doi: 10.3390/jcm9092920. J Clin Med. 2020. PMID: 32927780 Free PMC article.
-
Petatewalide B alleviates oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury via activation of the AMPK/Nrf2 signaling pathway.Mol Med Rep. 2020 Jul;22(1):239-246. doi: 10.3892/mmr.2020.11075. Epub 2020 Apr 16. Mol Med Rep. 2020. PMID: 32319645 Free PMC article.
-
Effects of lncRNA HOXA11-AS on Sevoflurane-Induced Neuronal Apoptosis and Inflammatory Responses by Regulating miR-98-5p/EphA4.Mediators Inflamm. 2023 Apr 5;2023:7750134. doi: 10.1155/2023/7750134. eCollection 2023. Mediators Inflamm. 2023. PMID: 37064501 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous